当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Creating an AI-first drug discovery engine
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2024-09-13 , DOI: 10.1038/d41573-024-00149-6
Asher Mullard

Najat Khan — Chief R&D Officer and Chief Commercial Officer at Recursion — discusses the proposed merger of Recursion and Exscientia.

中文翻译:


创建 AI 优先的药物发现引擎



Recursion 的首席研发官兼首席商务官 Najat Khan 讨论了 Recursion 和 Exscientia 的拟议合并。
更新日期:2024-09-13
down
wechat
bug